Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Vascular Neurology · Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Are Blood Thinners and Daily Aspirin Safe in CADASIL?

At a Glance

CADASIL alone does not automatically justify daily aspirin or a blood thinner to prevent a first stroke. A vascular neurologist should weigh previous blockage-related strokes, other medical needs, MRI microbleeds, blood pressure, and bleeding risk before recommending treatment.

Having CADASIL alone is not an automatic reason to start taking routine daily aspirin or an anticoagulant to prevent a first stroke. However, you should never start, stop, or change prescribed antiplatelet or anticoagulant medications without speaking to your doctor, as abruptly stopping them can cause harm [1][2]. The decision to use these medications requires a highly individualized balance between preventing blockages and avoiding brain bleeds.

Understanding the Terminology

To understand how doctors make this decision, it helps to know the key terms:

  • Antiplatelets (such as aspirin or clopidogrel): Medicines that keep blood components called platelets from sticking together.
  • Anticoagulants (such as warfarin or apixaban): Medicines that slow down the body’s process of making clots. These are not simply “stronger” versions of aspirin; they affect clotting in entirely different ways.
  • Ischemic stroke: A stroke caused by a blockage restricting blood flow.
  • Intracerebral hemorrhage: A severe bleeding stroke.
  • Cerebral microbleeds: Tiny spots of old leakage from fragile blood vessels, visible only on MRI scans.

The Delicate Balance: Blockages vs. Bleeds

CADASIL is a disease of the small blood vessels in the brain. It causes the vessel walls to thicken and narrow, which can restrict blood flow and lead to ischemic strokes. However, the disease also weakens these blood vessels, making them fragile and prone to leaking [3][4].

This fragility leads to cerebral microbleeds and carries a risk of a larger intracerebral hemorrhage. In a combined French and Taiwanese study of 552 CADASIL patients, a history of intracerebral hemorrhage was found in about 6.2%, confirming it as a recognized complication of the disease [5]. Because of this dual risk, prescribing medications that thin the blood is a complex decision. While antiplatelets like aspirin generally increase bleeding risk, evidence showing that they independently cause hemorrhages in CADASIL—or that they successfully prevent a first CADASIL stroke—is mostly limited to observational data [6][7]. Furthermore, cerebral microbleeds are markers of prior small-vessel leakage, not active bleeding; their presence does not automatically mean that all antiplatelet therapy is unsafe [4][8].

How Guidelines Apply to CADASIL

Medical decisions generally fall into different categories based on your medical history:

  • Primary Prevention (No prior stroke): The American Heart Association and American Stroke Association (AHA/ASA) guidelines for the general public do not recommend routine daily aspirin to prevent a first stroke unless there is a specific, established cardiovascular reason [1]. Because there is no CADASIL-specific evidence proving that daily aspirin prevents a first stroke, most specialists advise against taking it “just in case” [7][9].
  • Secondary Prevention (After a stroke): If you have already had a confirmed ischemic stroke or high-risk transient ischemic attack (TIA), doctors often consider prescribing an antiplatelet medication to reduce the risk of another one [10]. However, in CADASIL, symptoms of a TIA can sometimes be difficult to distinguish from a severe migraine aura, so careful evaluation is necessary [8].
  • Treatment for Other Conditions: If you have another condition, such as atrial fibrillation, an anticoagulant may be prescribed to prevent clots from the heart [2]. If you have a mechanical heart valve, warfarin is the established required anticoagulant; newer direct oral anticoagulants like apixaban cannot be substituted for mechanical valves [2].

Factors Your Doctor Will Consider

To determine what is safe for you, a vascular neurologist will look at several personalized factors rather than applying a one-size-fits-all rule [8][9]:

Factor How It Affects the Decision
Brain MRI Findings The number and distribution of cerebral microbleeds on your MRI help doctors gauge the overall health of your blood vessels and weigh the potential bleeding risks [4].
Blood Pressure High blood pressure (hypertension) is an independent risk factor for brain bleeds. Diligent blood pressure management is a critical, evidence-based intervention for reducing overall vascular risk [5][11].
Genetic Variant Certain NOTCH3 mutations (such as p.Arg544Cys and p.Arg75Pro) have been associated with different clinical patterns, including higher hemorrhage rates in some observational studies. However, your genotype alone does not determine your individual bleeding risk [5][12].
Other Medications Over-the-counter NSAIDs (like ibuprofen) and certain supplements can affect bleeding. You should always check with your neurologist or pharmacist before starting them [7].

Emergency Instructions

Because it is impossible to distinguish between an ischemic stroke (blockage) and an intracerebral hemorrhage (bleed) at home, call emergency services immediately if you or a loved one experience sudden facial droop, weakness or numbness in a limb, speech or vision changes, loss of coordination, seizure, confusion, or a sudden severe headache.

Do not try to diagnose the issue yourself, do not drive yourself to the hospital, and do not take an aspirin, as self-administering aspirin could severely worsen a bleeding stroke.

Common questions in this guide

Can I take daily aspirin if I have CADASIL?
CADASIL alone is not an automatic reason to take daily aspirin to prevent a first stroke. A clinician may consider aspirin after a confirmed blockage-related stroke or high-risk transient ischemic attack, or for another established cardiovascular reason, but the decision must account for bleeding risk.
Are blood thinners safe for people with CADASIL?
Blood thinners such as warfarin or apixaban are not automatically safe or unsafe in CADASIL; the choice depends on why they are needed and your risk of brain bleeding. They may be necessary for conditions such as atrial fibrillation, and warfarin is required for a mechanical heart valve, so do not stop one without medical advice.
Do cerebral microbleeds mean I cannot take aspirin?
No. Microbleeds are signs of earlier small-vessel leakage seen on an MRI, not proof that active bleeding is happening, and they do not automatically rule out aspirin or another platelet-blocking medicine. Their number and location help your specialist weigh possible benefit against bleeding risk.
What will my doctor consider before prescribing a blood thinner?
Your doctor may review why the medicine is needed, any prior stroke or possible transient ischemic attack, the number and pattern of MRI microbleeds, blood pressure, genetic findings, and other medicines or supplements. A vascular neurologist may coordinate with your cardiologist and pharmacist when recommendations overlap.
Should I take aspirin if I think I am having a stroke?
No—do not take aspirin to treat sudden stroke symptoms at home. A blockage-related stroke and a bleeding stroke can look alike, and aspirin could make a bleeding stroke worse; call emergency services immediately and do not drive yourself.
Can high blood pressure affect blood thinner decisions in CADASIL?
Yes. High blood pressure increases the risk of brain bleeding and places additional stress on fragile small vessels, so careful monitoring and treatment are important. Ask your care team for an individualized target and share your home readings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I have another condition that might require an antiplatelet or anticoagulant, how will we balance that with my CADASIL diagnosis?
  2. 2.Based on my MRI, how many cerebral microbleeds do I have, and how does that factor into our medication decisions?
  3. 3.What is my individualized target blood pressure range to minimize stress on my brain's blood vessels?
  4. 4.Was my previous transient episode definitely a TIA, or could it have been a CADASIL migraine aura?
  5. 5.Which specialist will coordinate decisions if my cardiologist and neurologist have competing medication recommendations?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry.

    Hira RS, Gosch KL, Kazi DS, et al.

    Circulation. Cardiovascular quality and outcomes 2022; (15(3)):e007979 doi:10.1161/CIRCOUTCOMES.121.007979.

    PMID: 35098732
  2. 2

    A Patient with Combined CADASIL and MTHFR Homozygosity.

    Ibrikji S, El Halabi T, Yamout B

    Case reports in neurological medicine 2020; (2020()):4980847 doi:10.1155/2020/4980847.

    PMID: 32128266
  3. 3

    Cerebral Microbleeds and the Risk of Incident Ischemic Stroke in CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy).

    Puy L, De Guio F, Godin O, et al.

    Stroke 2017; (48(10)):2699-2703 doi:10.1161/STROKEAHA.117.017839.

    PMID: 28842512
  4. 4

    Cerebral Microbleed Burdens in Specific Brain Regions Are Associated With Disease Severity of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

    Chung CP, Chen JW, Chang FC, et al.

    Journal of the American Heart Association 2020; (9(13)):e016233 doi:10.1161/JAHA.120.016233.

    PMID: 32552418
  5. 5

    Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

    Chen CH, Cheng YW, Zhang R, et al.

    Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.

    PMID: 40270244
  6. 6

    Aspirin for Primary Prevention of Cardiovascular Events.

    Abdelaziz HK, Saad M, Pothineni NVK, et al.

    Journal of the American College of Cardiology 2019; (73(23)):2915-2929 doi:10.1016/j.jacc.2019.03.501.

    PMID: 31196447
  7. 7

    Antiplatelet use and CADASIL: a retrospective observational analysis.

    Muppa J, Yaghi S, Goldstein ED

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(8)):2831-2834 doi:10.1007/s10072-023-06773-1.

    PMID: 36966219
  8. 8

    Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

    Mancuso M, Arnold M, Bersano A, et al.

    European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.

    PMID: 32196841
  9. 9

    Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.

    Meschia JF, Worrall BB, Elahi FM, et al.

    Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.

    PMID: 37602377
  10. 10

    Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.

    Moustafa B, Testai FD

    Current neurology and neuroscience reports 2022; (22(11)):789-802 doi:10.1007/s11910-022-01237-z.

    PMID: 36227497
  11. 11

    Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.

    Chabriat H, Hervé D, Duering M, et al.

    Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.

    PMID: 26578659
  12. 12

    Pro-Hemorrhagic Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Associated with NOTCH3 p.R75P Mutation with Low Vascular NOTCH3 Aggregation Property.

    Ishiyama H, Kim H, Saito S, et al.

    Annals of neurology 2024; (95(6)):1040-1054 doi:10.1002/ana.26916.

    PMID: 38520151

This page is for informational purposes only and does not constitute medical advice about CADASIL or blood-thinning medicines. Do not start, stop, or change aspirin, an anticoagulant, or any prescribed medicine without speaking with your doctor.

Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.